195 related articles for article (PubMed ID: 18707140)
1. In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: insights into the hepatotoxicity of sudoxicam.
Obach RS; Kalgutkar AS; Ryder TF; Walker GS
Chem Res Toxicol; 2008 Sep; 21(9):1890-9. PubMed ID: 18707140
[TBL] [Abstract][Full Text] [Related]
2. Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose.
Obach RS; Kalgutkar AS; Soglia JR; Zhao SX
Chem Res Toxicol; 2008 Sep; 21(9):1814-22. PubMed ID: 18690722
[TBL] [Abstract][Full Text] [Related]
3. Dual mechanisms suppress meloxicam bioactivation relative to sudoxicam.
Barnette DA; Schleiff MA; Osborn LR; Flynn N; Matlock M; Swamidass SJ; Miller GP
Toxicology; 2020 Jul; 440():152478. PubMed ID: 32437779
[TBL] [Abstract][Full Text] [Related]
4. Meloxicam methyl group determines enzyme specificity for thiazole bioactivation compared to sudoxicam.
Barnette DA; Schleiff MA; Datta A; Flynn N; Swamidass SJ; Miller GP
Toxicol Lett; 2021 Mar; 338():10-20. PubMed ID: 33253783
[TBL] [Abstract][Full Text] [Related]
5. A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif.
Kalgutkar AS; Driscoll J; Zhao SX; Walker GS; Shepard RM; Soglia JR; Atherton J; Yu L; Mutlib AE; Munchhof MJ; Reiter LA; Jones CS; Doty JL; Trevena KA; Shaffer CL; Ripp SL
Chem Res Toxicol; 2007 Dec; 20(12):1954-65. PubMed ID: 17935300
[TBL] [Abstract][Full Text] [Related]
6. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
[TBL] [Abstract][Full Text] [Related]
7. Bioactivation of isothiazoles: minimizing the risk of potential toxicity in drug discovery.
Teffera Y; Choquette D; Liu J; Colletti AE; Hollis LS; Lin MH; Zhao Z
Chem Res Toxicol; 2010 Nov; 23(11):1743-52. PubMed ID: 20825217
[TBL] [Abstract][Full Text] [Related]
8. Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes.
Nadanaciva S; Aleo MD; Strock CJ; Stedman DB; Wang H; Will Y
Toxicol Appl Pharmacol; 2013 Oct; 272(2):272-80. PubMed ID: 23811329
[TBL] [Abstract][Full Text] [Related]
9. In vitro exploration of potential mechanisms of toxicity of the human hepatotoxic drug fenclozic acid.
Rodrigues AV; Rollison HE; Martin S; Sarda S; Schulz-Utermoehl T; Stahl S; Gustafsson F; Eakins J; Kenna JG; Wilson ID
Arch Toxicol; 2013 Aug; 87(8):1569-79. PubMed ID: 23609606
[TBL] [Abstract][Full Text] [Related]
10. Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network.
Xu S; Hermanson DJ; Banerjee S; Ghebreselasie K; Clayton GM; Garavito RM; Marnett LJ
J Biol Chem; 2014 Mar; 289(10):6799-6808. PubMed ID: 24425867
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic studies on the metabolic scission of thiazolidinedione derivatives to acyclic thiols.
Reddy VB; Karanam BV; Gruber WL; Wallace MA; Vincent SH; Franklin RB; Baillie TA
Chem Res Toxicol; 2005 May; 18(5):880-8. PubMed ID: 15892582
[TBL] [Abstract][Full Text] [Related]
12. In vitro hepatic microsomal metabolism of meloxicam in koalas (Phascolarctos cinereus), brushtail possums (Trichosurus vulpecula), ringtail possums (Pseudocheirus peregrinus), rats (Rattus norvegicus) and dogs (Canis lupus familiaris).
Kimble B; Li KM; Valtchev P; Higgins DP; Krockenberger MB; Govendir M
Comp Biochem Physiol C Toxicol Pharmacol; 2014 Apr; 161():7-14. PubMed ID: 24345479
[TBL] [Abstract][Full Text] [Related]
13. Interactions of human serum albumin with meloxicam: characterization of binding site.
Trynda-Lemiesz L; Wiglusz K
J Pharm Biomed Anal; 2010 Jun; 52(2):300-4. PubMed ID: 20089378
[TBL] [Abstract][Full Text] [Related]
14. Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivity.
Lazer ES; Miao CK; Cywin CL; Sorcek R; Wong HC; Meng Z; Potocki I; Hoermann M; Snow RJ; Tschantz MA; Kelly TA; McNeil DW; Coutts SJ; Churchill L; Graham AG; David E; Grob PM; Engel W; Meier H; Trummlitz G
J Med Chem; 1997 Mar; 40(6):980-9. PubMed ID: 9083488
[TBL] [Abstract][Full Text] [Related]
15. Can in vitro metabolism-dependent covalent binding data distinguish hepatotoxic from nonhepatotoxic drugs? An analysis using human hepatocytes and liver S-9 fraction.
Bauman JN; Kelly JM; Tripathy S; Zhao SX; Lam WW; Kalgutkar AS; Obach RS
Chem Res Toxicol; 2009 Feb; 22(2):332-40. PubMed ID: 19161298
[TBL] [Abstract][Full Text] [Related]
16. In vitro microsomal metabolic studies on a selective mGluR5 antagonist MTEP: characterization of in vitro metabolites and identification of a novel thiazole ring opening aldehyde metabolite.
Yang X; Chen W
Xenobiotica; 2005 Aug; 35(8):797-809. PubMed ID: 16278192
[TBL] [Abstract][Full Text] [Related]
17. Bioactivation of phencyclidine in rat and human liver microsomes and recombinant P450 2B enzymes: evidence for the formation of a novel quinone methide intermediate.
Driscoll JP; Kornecki K; Wolkowski JP; Chupak L; Kalgutkar AS; O'Donnell JP
Chem Res Toxicol; 2007 Oct; 20(10):1488-97. PubMed ID: 17892269
[TBL] [Abstract][Full Text] [Related]
18. Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac.
Shen S; Marchick MR; Davis MR; Doss GA; Pohl LR
Chem Res Toxicol; 1999 Feb; 12(2):214-22. PubMed ID: 10027801
[TBL] [Abstract][Full Text] [Related]
19. Direct binding of Cu(II)-complexes of oxicam NSAIDs with DNA backbone.
Roy S; Banerjee R; Sarkar M
J Inorg Biochem; 2006 Aug; 100(8):1320-31. PubMed ID: 16684565
[TBL] [Abstract][Full Text] [Related]
20. Activation of human cytochrome P-450 3A4-catalyzed meloxicam 5'-methylhydroxylation by quinidine and hydroquinidine in vitro.
Ludwig E; Schmid J; Beschke K; Ebner T
J Pharmacol Exp Ther; 1999 Jul; 290(1):1-8. PubMed ID: 10381752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
